ACG Equity Partners
3
24M
3
2
1
- Areas of investment
Summary
The company was established in North America in United States. The main department of described Corporate Investor is located in the Charleston.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the ACG Equity Partners, startups are often financed by Starquest Capital, Paca Investissement, Gravitation. The meaningful sponsors for the fund in investment in the same round are Sigma Gestion, Gravitation, Galen Partners. In the next rounds fund is usually obtained by NTT DOCOMO Ventures, SPDG.
We can highlight the next thriving fund investment areas, such as Medical, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight RxResults. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The fund is generally included in less than 2 deals every year. This ACG Equity Partners works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2014. Speaking about the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 2
- Exits
- 1
- Investments by industry
- Health Care (2)
- Pharmaceutical (2)
- Medical (2)
- Renewable Energy (1)
- Electronics (1) Show 2 more
- Investments by region
-
- United States (2)
- France (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
- Avg. company exit year
- 3
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| JDS Pharmaceuticals LLC. | 17 Nov 2004 | Health Care, Medical, Pharmaceutical | Early Stage Venture | 62M | United States, Pennsylvania |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.